Hundreds of lawsuits have been filed against Sanofi-Aventis, the makers of the popular chemotherapy medication Taxotere. The drug is used to make the chemotherapy experience smoother and help speed the process of recovery. However, many women taking Taxotere during chemotherapy for breast cancer have experienced…
The wave of litigation stemming from Xarelto bleeding complications continues to grow. There are now almost 7,000 pending lawsuits, including 2,800 federal cases that have been consolidated into multidistrict litigation and being overseen by the Honorable Judge Eldon E. Fallon in the Eastern District…
For frequent heartburn sufferers, doctors often prescribe Proton Pump Inhibitors (PPIs), which work by reducing the amount of acid in the stomach. The drugs are so popular in fact, that the PPI market is worth over $10 billion in the U.S. alone and the three…
A recent academic medical study provides a solid scientific basis to prove that highly advertised “Low T” drugs AndroGel and Axiron and others are causing heart attacks, strokes, and blood clots in men taking these drugs. The study referred to as the Finkle Study is entitled…
A British medical study released this week in the online edition of the Archives of Internal Medicine reports that the diabetes drug Actos can increase the risk of vision loss from macular edema....
In anticipation of a wave of lawsuits, the federal courts have issued an order coordinating the Actos bladder cancer lawsuits before one judge in the United States District Court for the...
The diabetes drug Actos has been associated with bladder cancer and the FDA has now required the manufacturer to provide warnings of this risk. Prior to 2011 Actos manufacturer Takeda...
A lawsuit filed February 16, 2011 by Zimmer, an orthopaedic device manufacturer, against consumer justice attorneys raises some interesting questions about defective or recalled products litigation...
The FDA recall of Darvocet and Darvon which are the trade names for propoxyphene was long overdue. These drugs have been on the market for over 50 years. The FDA memorandum dated November 19, 2010...